Tech Company M&A Transactions
Predix Pharmaceuticals Holdings Acquisition
On 4/3/2006, Predix Pharmaceuticals Holdings was acquired by EPIX Pharmaceuticals. EPIX Pharmaceuticals said the transaction price was $125 million.
Transaction Overview
Company Name
Acquired By
Announced On
4/3/2006
Transaction Type
M&A
Amount
$125,000,000
M&A Terms
Upon completion of the merger EPIX will issue to Predix stockholders shares of EPIX common stock such that Predix stockholders will own approximately 47% of the combined company's shares outstanding, and EPIX stockholders will own approximately 53%. Predix options and warrants outstanding at closing will also be assumed by EPIX. Predix's stockholders and option and warrant holders will be entitled to a milestone payment of $35 million upon Predix's achievement of certain clinical or strategic milestones.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
4 Maguire Road
Lexington, MA 02421
USA
Lexington, MA 02421
USA
Phone
Website
Email Address
Not Recorded
Overview
Predix Pharmaceuticals is a privately held drug development company integrating computational and medicinal chemistry to rapidly and efficiently create new drugs targeted to GPCRs and ion channels.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 4/3/2006: Pivot Trader venture capital transaction
Next: 4/3/2006: Teneros venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs